-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Initiates Coverage On Odyssey Therapeutics with Overweight Rating, Announces Price Target of $26

Benzinga·06/02/2026 13:04:38
Listen to the news
JP Morgan analyst Brian Cheng initiates coverage on Odyssey Therapeutics (NASDAQ:ODTX) with a Overweight rating and announces Price Target of $26.